TL;DR
- An Lp(a) blood test flags inherited heart risk that a routine lipid panel does not measure at all.
- Most 2026 lipid guidelines flag Lp(a) above roughly 50 mg/dL or 125 nmol/L as elevated risk.
- GoodLife Health includes Lp(a) in its quarterly Biomarker Audit alongside ApoB, hs-CRP, and HbA1c.
- No FDA-approved drug lowers Lp(a) directly in 2026, so management leans harder on ApoB, LDL, and inflammation.
- Test once in adulthood in most cases; repeat testing rarely changes the plan unless the first assay was unreliable.
- Lp(a) sits outside the standard lipid panel entirely and has to be ordered by name.
- Roughly one in five adults carries an elevated Lp(a) level, regardless of family history.
- Statins, diet, and exercise don't move Lp(a) — the response is to tighten LDL, ApoB, blood pressure, and hs-CRP instead.
- Most adults only need one Lp(a) test in a lifetime since the level is genetically fixed.
- GoodLife Health runs Lp(a) automatically every 90 days as part of its Cardiometabolic Optimization Biomarker Audit.
Why This Matters
LDL cholesterol tells part of the cardiovascular story. Lp(a) is inherited, present from birth, and largely untouched by diet, exercise, or statin therapy. Roughly one in five adults carries an elevated level, and most never find out until a cardiac event forces the question onto the table.
That's the gap a standard annual physical doesn't close. A routine lipid panel checks total cholesterol, LDL, HDL, and triglycerides — Lp(a) sits outside that panel entirely and has to be ordered by name.
GoodLife Health's Cardiometabolic Optimization Membership runs Lp(a) as part of a comprehensive Biomarker Audit every 90 days, alongside ApoB, hs-CRP, HbA1c, and full hormone and thyroid panels. The logic is straightforward: weight, hormones, blood sugar, and heart risk move as one system in the body, so the labs should be read as one system too, not as isolated numbers on separate reports.
What You Need Before You Order an Lp(a) Test
- A clinician willing to write the order. Many routine physicals stop at a standard lipid panel and never touch Lp(a) unless a patient or physician specifically requests it.
- No fasting required. Lp(a) doesn't shift with food intake the way triglycerides do, so it can ride along with almost any blood draw.
- Family history details. A parent or sibling with a heart attack or stroke before age 55 (men) or 65 (women) is one of the strongest reasons to test.
- Your most recent LDL, ApoB, and hs-CRP numbers. Lp(a) makes the most sense read next to the rest of your lipid panel, not in isolation.
- A plan for what happens after the result. A test without a follow-up conversation about ApoB and LDL targets is a number with no action attached.
A result near the elevated-risk line — roughly 50 mg/dL or 125 nmol/L — especially paired with a family history of early heart disease, is worth a direct conversation, not a wait-and-see approach.
How Lp(a) Testing Works, Step by Step
1. Ask for Lp(a) by name
Most standard lipid panels don't automatically include Lp(a) — it has to be written as its own line item on the lab order. If your clinician hasn't mentioned it and you have a family history of early heart disease, ask directly.
2. Get the blood draw
One draw, no fasting window, and turnaround is typically a few days depending on the lab network running the assay. There's no special prep beyond what your clinician requests for the rest of the panel.
3. Learn which unit your result uses
Labs report Lp(a) in either mg/dL or nmol/L, and the two units don't convert with a simple fixed multiplier because they measure different physical properties of the particle. Mixing them up is the single most common source of confusion patients bring to a follow-up visit.
4. Compare your number to the elevated-risk threshold
Most 2026 lipid guidelines consider levels above roughly 50 mg/dL or 125 nmol/L to carry meaningfully elevated cardiovascular risk. A result near that line, especially paired with a family history of early heart disease, is worth a direct conversation, not a wait-and-see approach.
5. Read Lp(a) next to ApoB and LDL
Lp(a) doesn't replace ApoB testing — it adds to it. ApoB counts the total number of atherogenic particles circulating in your blood; Lp(a) tells you whether a genetically riskier particle type is part of that count. Together they give a fuller risk picture than LDL alone ever could.
6. Decide what actually changes
Statins don't move Lp(a) in any meaningful way, and neither does cutting saturated fat or adding cardio. What does change is how aggressively everything else modifiable gets treated: LDL, ApoB, blood pressure, and hs-CRP all get pushed toward tighter targets when Lp(a) comes back high, because those are the levers that are actually adjustable.
What Actually Moves the Numbers
Lp(a) is genetic; the rest of the panel is modifiable
| Lever | Effect on Lp(a) | What happens instead |
|---|---|---|
| Statins | No meaningful change | LDL and ApoB targets get pushed tighter |
| Cutting saturated fat | No meaningful change | Focus shifts to blood pressure and hs-CRP |
| Adding cardio | No meaningful change | Every other modifiable risk factor gets treated harder |
7. Know when to retest
Because Lp(a) is set genetically, most adults test once and never need to repeat it. Retesting usually only happens if you start a therapy specifically known to shift Lp(a), or if the first result came from an assay your clinician has reason to distrust.
Troubleshooting Common Lp(a) Testing Problems
- "My doctor said Lp(a) isn't necessary." Ask directly for the order and cite family history if it applies — it's rarely included in a default panel, and most clinicians will add it on request.
- "My result is in nmol/L and the threshold I read was in mg/dL." Don't convert with a flat multiplier. Ask your clinician to interpret the number using the exact units printed on your lab report.
- "My Lp(a) came back high and nothing changed at my visit." That's a signal to push harder on ApoB, LDL, and hs-CRP targets, since Lp(a) itself has no direct FDA-approved treatment in 2026.
- "I have no family history — do I still need it?" Yes. Roughly one in five adults carries an elevated level regardless of documented family history, which is why some 2026 guidelines support once-in-a-lifetime testing for all adults.
- "My insurance denied the test." Cash-pay Lp(a) testing is inexpensive relative to the cost of a cardiac event. Ask whether it can be bundled into a broader metabolic or cardiovascular panel instead of billed as a standalone line item.
Tools and Resources
A handful of related labs and context pieces make an Lp(a) result easier to act on rather than just file away:
- A comprehensive lipid panel that reports LDL, HDL, and triglycerides alongside Lp(a), so the whole cholesterol picture sits in one place.
- An ApoB test, which counts atherogenic particles directly rather than estimating them from LDL alone.
- An hs-CRP result, which flags the inflammation that often compounds genetic lipid risk.
- A record of family cardiac history going back at least one generation, since it changes how aggressively a high Lp(a) result gets treated.
GoodLife Health runs all four of these — Lp(a), ApoB, hs-CRP, and a full lipid panel — inside the same quarterly Biomarker Audit rather than as separate add-on orders, because a cardiometabolic optimization approach treats them as one report, not four.
FAQ
What is a normal Lp(a) level?
Most 2026 lipid guidelines consider levels below roughly 50 mg/dL or 125 nmol/L to carry average cardiovascular risk. Anything above that threshold, especially with a family history of early heart disease, warrants a direct conversation with your clinician.
Is Lp(a) the same as LDL cholesterol?
No. Lp(a) is a distinct particle that carries a genetically determined risk marker LDL doesn't have, and it's measured separately from a standard LDL result. A patient can have normal LDL and still carry elevated Lp(a).
Can I lower my Lp(a) with diet or exercise?
Diet and exercise have little measurable effect on Lp(a) because the level is set almost entirely by genetics. Management instead focuses on lowering every other modifiable risk factor, including LDL, ApoB, and blood pressure.
How often should I get an Lp(a) blood test?
Most adults only need an Lp(a) blood test once in a lifetime, since the level doesn't change meaningfully over time. Retesting is typically reserved for cases involving a therapy known to affect it or a questionable first result.
Does insurance cover Lp(a) testing?
Coverage varies by plan, and some insurers still treat it as a non-routine order. Cash-pay pricing for a standalone Lp(a) test is generally low relative to broader cardiovascular workups.
What's the difference between Lp(a) and ApoB?
ApoB counts the total number of atherogenic particles in the blood, while Lp(a) identifies whether a specific, genetically riskier particle type is part of that count. The two are read together, not as substitutes for each other.
Is there a medication that treats high Lp(a) in 2026?
No FDA-approved medication directly lowers Lp(a) as of 2026. Clinicians instead treat the rest of the cardiometabolic system harder — LDL, ApoB, blood pressure, and inflammation — to offset the added risk.
Should my children get tested if my Lp(a) is high?
Because Lp(a) is inherited, a first-degree relative's elevated result is a reasonable trigger to discuss testing with a pediatrician or primary care physician. Family-level awareness lets the next generation act earlier rather than discovering risk after a cardiac event.
Lp(a) is set at birth and stays essentially flat for life, which means the test you get in 2026 is likely the only Lp(a) result you'll ever need.
One Last Thing
Lp(a) is set at birth and stays essentially flat for life, which means the test you get in 2026 is likely the only Lp(a) result you'll ever need. That's exactly why it belongs inside a standing lab cadence rather than a one-off add-on order — GoodLife Health builds it into every quarterly Biomarker Audit by default, so patients aren't relying on remembering to ask for it during a rushed annual visit.
Related Guides
- Advanced cardiometabolic labs beyond a standard lipid panel
- Direct primary care for high cholesterol management
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/